Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Albendazole Sulfoxide Plasma Levels and Efficacy of Antiparasitic Treatment in Patients With Parenchymal Neurocysticercosis.

Arroyo G, Bustos JA, Lescano AG, Gonzales I, Saavedra H, Rodriguez S, Pretell EJ, Bonato PS, Lanchote VL, Takayanagui OM, Horton J, Gonzalez AE, Gilman RH, Garcia HH; Cysticercosis Working Group in Peru .

Clin Infect Dis. 2019 Nov 13;69(11):1996-2002. doi: 10.1093/cid/ciz085.

2.

Short Communication: Human Bone Marrow Stromal Cells Exhibit Immunosuppressive Effects on Human T Lymphotropic Virus Type 1 T Lymphocyte from Infected Individuals.

Rodrigues ES, de Macedo MD, Orellana MD, Takayanagui OM, Palma PVB, Pinto MT, de Oliveira GLV, Malmegrim KCR, Slavov SN, Covas DT, Kashima S.

AIDS Res Hum Retroviruses. 2019 Feb;35(2):164-168. doi: 10.1089/AID.2018.0066. Epub 2018 Dec 22.

PMID:
30351194
3.

Detection of HTLV-1 proviral DNA in BM mononuclear cells and cultured mesenchymal stromal cells isolated from patients with HTLV-1 infection.

Rodrigues ES, do Carmo Favarin M, de Macedo MD, Otaguiri KK, Orellana MD, Takayanagui OM, Palma PVB, Slavov SN, Covas DT, Kashima S.

Virology. 2018 Jun;519:145-155. doi: 10.1016/j.virol.2018.04.014. Epub 2018 Apr 30.

4.

Analysis of unbound plasma concentration of oxcarbazepine and the 10-hydroxycarbazepine enantiomers by liquid chromatography with tandem mass spectrometry in healthy volunteers.

Antunes NJ, Wichert-Ana L, Coelho EB, Della Pasqua O, Alexandre Junior V, Takayanagui OM, Marques MP, Lanchote VL.

J Pharm Biomed Anal. 2018 Feb 5;149:442-447. doi: 10.1016/j.jpba.2017.11.041.

PMID:
29169112
5.

Fluconazole levels in serum and cerebrospinal fluid according to daily dosage in patients with cryptococcosis and other fungal infections.

Schiave LA, Nascimento E, Vilar FC, de Haes TM, Takayanagui OM, Gaitani CM, Martinez R.

Braz J Infect Dis. 2018 Jan - Feb;22(1):11-15. doi: 10.1016/j.bjid.2017.10.003. Epub 2017 Nov 13.

6.

Noninvasive intracranial pressure monitoring for HIV-associated cryptococcal meningitis.

Bollela VR, Frigieri G, Vilar FC, Spavieri DL Jr, Tallarico FJ, Tallarico GM, Andrade RAP, de Haes TM, Takayanagui OM, Catai AM, Mascarenhas S.

Braz J Med Biol Res. 2017 Aug 7;50(9):e6392. doi: 10.1590/1414-431X20176392.

7.

Downregulation of histone methyltransferase EHMT2 in CD4+ T-cells may protect HTLV-1-infected individuals against HAM/TSP development.

Colaço CS, de Matos AR, Estrêla MS, Rocha-Júnior MC, Otaguiri KK, Rodrigues ES, Takayanagui OM, Covas DT, Kashima S, Pittella Silva F, Haddad R.

Arch Virol. 2017 Oct;162(10):3131-3136. doi: 10.1007/s00705-017-3428-8. Epub 2017 Jun 12.

PMID:
28608127
8.

Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects.

Antunes NJ, van Dijkman SC, Lanchote VL, Wichert-Ana L, Coelho EB, Alexandre Junior V, Takayanagui OM, Tozatto E, van Hasselt JGC, Della Pasqua O.

Eur J Pharm Sci. 2017 Nov 15;109S:S116-S123. doi: 10.1016/j.ejps.2017.05.034. Epub 2017 May 17.

PMID:
28528287
9.

Zika Virus Meningoencephalitis in an Immunocompromised Patient.

Schwartzmann PV, Ramalho LN, Neder L, Vilar FC, Ayub-Ferreira SM, Romeiro MF, Takayanagui OM, Dos Santos AC, Schmidt A, Figueiredo LT, Arena R, Simões MV.

Mayo Clin Proc. 2017 Mar;92(3):460-466. doi: 10.1016/j.mayocp.2016.12.019.

PMID:
28259231
10.

Clinical Symptoms, Imaging Features and Cyst Distribution in the Cerebrospinal Fluid Compartments in Patients with Extraparenchymal Neurocysticercosis.

Bazan R, Hamamoto Filho PT, Luvizutto GJ, Nunes HR, Odashima NS, Dos Santos AC, Elias Júnior J, Zanini MA, Fleury A, Takayanagui OM.

PLoS Negl Trop Dis. 2016 Nov 9;10(11):e0005115. doi: 10.1371/journal.pntd.0005115. eCollection 2016 Nov.

11.

HLA-G 3'-untranslated region polymorphisms are associated with HTLV-1 infection, proviral load and HTLV-associated myelopathy/tropical spastic paraparesis development.

Cilião Alves DC, Haddad R, Rocha-Júnior MC, de Deus Wagatsuma VM, Martelli-Palomino G, Marques AA, Takayanagui OM, Covas DT, Kashima S, Donadi EA.

J Gen Virol. 2016 Oct;97(10):2742-2752. doi: 10.1099/jgv.0.000559. Epub 2016 Jul 22.

PMID:
27449667
12.

Predictors of quality of life after moderate to severe traumatic brain injury.

Weber KT, Guimarães VA, Pontes Neto OM, Leite JP, Takayanagui OM, Santos-Pontelli TE.

Arq Neuropsiquiatr. 2016 May;74(5):409-15. doi: 10.1590/0004-282X20160053.

13.

Refractory and/or Relapsing Cryptococcosis Associated with Acquired Immune Deficiency Syndrome: Clinical Features, Genotype, and Virulence Factors of Cryptococcus spp. Isolates.

Nascimento E, Vitali LH, Tonani L, Kress MR, Takayanagui OM, Martinez R.

Am J Trop Med Hyg. 2016 May 4;94(5):975-81. doi: 10.4269/ajtmh.15-0595. Epub 2016 Feb 29.

14.

Evaluation of postural balance in mild cognitive impairment through a three-dimensional electromagnetic system.

Borges AP, Carneiro JA, Zaia JE, Carneiro AA, Takayanagui OM.

Braz J Otorhinolaryngol. 2016 Jul-Aug;82(4):433-41. doi: 10.1016/j.bjorl.2015.08.023. Epub 2015 Dec 23.

15.
16.

Antiviral treatment for Bell's palsy (idiopathic facial paralysis).

Takayanagui OM.

Sao Paulo Med J. 2015 Jul-Aug;133(4):383. doi: 10.1590/1516-3180.20151334T1. No abstract available.

17.

Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers.

Antunes Nde J, Wichert-Ana L, Coelho EB, Della Pasqua O, Alexandre Junior V, Takayanagui OM, Tozatto E, Marques MP, Lanchote VL.

Eur J Clin Pharmacol. 2016 Feb;72(2):195-201. doi: 10.1007/s00228-015-1970-4. Epub 2015 Oct 30.

PMID:
26514967
18.

T cell receptor signaling pathway is overexpressed in CD4(+) T cells from HAM/TSP individuals.

Pinto MT, Malta TM, Rodrigues ES, Takayanagui OM, Tanaka Y, Covas DT, Kashima S.

Braz J Infect Dis. 2015 Nov-Dec;19(6):578-84. doi: 10.1016/j.bjid.2015.07.008. Epub 2015 Sep 8.

19.

Neuroimaging observations linking neurocysticercosis and mesial temporal lobe epilepsy with hippocampal sclerosis.

Bianchin MM, Velasco TR, Wichert-Ana L, Araújo D Jr, Alexandre V Jr, Scornavacca F, Escorsi-Rosset SR, dos Santos AC, Carlotti CG Jr, Takayanagui OM, Sakamoto AC.

Epilepsy Res. 2015 Oct;116:34-9. doi: 10.1016/j.eplepsyres.2015.07.001. Epub 2015 Jul 6.

PMID:
26354165
20.

Analysis of cerebrospinal fluid in racemose form of neurocysticercosis.

Bazan R, Odashima NS, Luvizutto GJ, Hamamoto Filho PT, Zanini MA, Takayanagui OM.

Arq Neuropsiquiatr. 2015 Oct;73(10):852-5. doi: 10.1590/0004-282X20150120. Epub 2015 Aug 18.

21.

Cross-cultural adaptation and validation of the episodic autobiographic memory interview for Brazilian Portuguese.

Rodrigues GR, Oliveira DS, Foss MP, Takayanagui OM.

Arq Neuropsiquiatr. 2015 Aug;73(8):676-80. doi: 10.1590/0004-282X20150084.

22.

In response: Multifactorial basis of epilepsy in patients with neurocysticercosis.

Nash TE, Mahanty S, Loeb JA, Theodore WH, Friedman A, Sander JW, Singh G, Cavalheiro E, Del Brutto OH, Takayanagui OM, Fleury A, Verastegui M, Preux PM, Montano S, Pretell EJ, White AC Jr, Gonzales AE, Gilman RH, Garcia HH.

Epilepsia. 2015 Jun;56(6):975-6. doi: 10.1111/epi.12986. No abstract available.

23.

Neurocysticercosis: A natural human model of epileptogenesis.

Nash TE, Mahanty S, Loeb JA, Theodore WH, Friedman A, Sander JW, Singh G, Cavalheiro E, Del Brutto OH, Takayanagui OM, Fleury A, Verastegui M, Preux PM, Montano S, Pretell EJ, White AC Jr, Gonzales AE, Gilman RH, Garcia HH.

Epilepsia. 2015 Feb;56(2):177-83. doi: 10.1111/epi.12849. Epub 2014 Dec 23. Review.

24.

Characteristics of mesial temporal lobe epilepsy associated with hippocampal sclerosis plus neurocysticercosis.

Bianchin MM, Velasco TR, Wichert-Ana L, Alexandre V Jr, Araujo D Jr, dos Santos AC, Carlotti CG Jr, Takayanagui OM, Sakamoto AC.

Epilepsy Res. 2014 Dec;108(10):1889-95. doi: 10.1016/j.eplepsyres.2014.09.018. Epub 2014 Oct 11.

PMID:
25306064
25.

Usefulness and limitations of polymerase chain reaction in the etiologic diagnosis of neurotoxoplasmosis in immunocompromised patients.

Anselmo LM, Vilar FC, Lima JE, Yamamoto AY, Bollela VR, Takayanagui OM.

J Neurol Sci. 2014 Nov 15;346(1-2):231-4. doi: 10.1016/j.jns.2014.08.034. Epub 2014 Aug 30.

PMID:
25240445
26.

HTLV-1 infects human mesenchymal stromal cell in vitro and modifies their phenotypic characteristics.

Rodrigues ES, de Macedo MD, Pinto MT, Orellana MD, Rocha Junior MC, de Magalhães DA, Tanaka Y, Takayanagui OM, Covas DT, Kashima S.

Virology. 2014 Jan 20;449:190-9. doi: 10.1016/j.virol.2013.11.022. Epub 2013 Dec 6.

27.

Neurocysticercosis.

Takayanagui OM.

Arq Neuropsiquiatr. 2013 Sep;71(9B):710-3. doi: 10.1590/0004-282X20130156. Review.

28.

Analysis of oxcarbazepine and the 10-hydroxycarbazepine enantiomers in plasma by LC-MS/MS: application in a pharmacokinetic study.

de Jesus Antunes N, Wichert-Ana L, Coelho EB, Della Pasqua O, Alexandre V Jr, Takayanagui OM, Tozatto E, Lanchote VL.

Chirality. 2013 Dec;25(12):897-903. doi: 10.1002/chir.22231. Epub 2013 Sep 30.

PMID:
24123382
29.

Genes related to antiviral activity, cell migration, and lysis are differentially expressed in CD4(+) T cells in human t cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients.

Pinto MT, Malta TM, Rodrigues ES, Pinheiro DG, Panepucci RA, Malmegrim de Farias KC, Sousa Ade P, Takayanagui OM, Tanaka Y, Covas DT, Kashima S.

AIDS Res Hum Retroviruses. 2014 Jun;30(6):610-22. doi: 10.1089/AID.2013.0109. Epub 2013 Oct 16.

30.

Cognitive and surgical outcome in mesial temporal lobe epilepsy associated with hippocampal sclerosis plus neurocysticercosis: a cohort study.

Bianchin MM, Velasco TR, Coimbra ER, Gargaro AC, Escorsi-Rosset SR, Wichert-Ana L, Terra VC, Alexandre V Jr, Araujo D Jr, dos Santos AC, Fernandes RM, Assirati JA Jr, Carlotti CG Jr, Leite JP, Takayanagui OM, Markowitsch HJ, Sakamoto AC.

PLoS One. 2013 Apr 22;8(4):e60949. doi: 10.1371/journal.pone.0060949. Print 2013.

31.

Modulation of angiogenic factor VEGF by DNA-hsp65 vaccination in a murine CNS tuberculosis model.

Zucchi FC, Tsanaclis AM, Moura-Dias Q Jr, Silva CL, Pelegrini-da-Silva A, Neder L, Takayanagui OM.

Tuberculosis (Edinb). 2013 May;93(3):373-80. doi: 10.1016/j.tube.2013.02.002. Epub 2013 Mar 13.

PMID:
23491717
32.

Altered expression of degranulation-related genes in CD8+ T cells in human T lymphotropic virus type I infection.

Malta TM, Silva IT, Pinheiro DG, Santos AR, Pinto MT, Panepucci RA, Takayanagui OM, Tanaka Y, Covas DT, Kashima S.

AIDS Res Hum Retroviruses. 2013 May;29(5):826-36. doi: 10.1089/AID.2012.0205. Epub 2013 Feb 5.

PMID:
23301858
33.

Leukotrienes are upregulated and associated with human T-lymphotropic virus type 1 (HTLV-1)-associated neuroinflammatory disease.

Trindade BC, Sorgi CA, Nicolete LD, Malta TM, Pinto MT, Takayanagui OM, Covas DT, Martins Filho OA, Kashima S, Faccioli LH.

PLoS One. 2012;7(12):e51873. doi: 10.1371/journal.pone.0051873. Epub 2012 Dec 20.

34.

A new method to analyze the subjective visual vertical in patients with bilateral vestibular dysfunction.

Funabashi M, Santos-Pontelli TE, Colafêmina JF, Pavan TZ, Carneiro AA, Takayanagui OM.

Clinics (Sao Paulo). 2012 Oct;67(10):1127-31.

35.

Upregulation of hsa-miR-125b in HTLV-1 asymptomatic carriers and HTLV-1-associated myelopathy/tropical spastic paraparesis patients.

Nicolete LD, Nicolete R, Haddad R, Azevedo R, Castro FA, Tanaka Y, Takayanagui OM, Covas DT, Kashima S.

Mem Inst Oswaldo Cruz. 2012 Sep;107(6):824-7.

36.

HTLV-1/2 seroprevalence and coinfection rate in Brazilian first-time blood donors: an 11-year follow-up.

Pinto MT, Rodrigues ES, Malta TM, Azevedo R, Takayanagui OM, Valente VB, Ubiali EM, Covas DT, Kashima S.

Rev Inst Med Trop Sao Paulo. 2012 May-Jun;54(3):123-9.

37.

Interleukin-18 and interferon-gamma polymorphisms are implicated on proviral load and susceptibility to human T-lymphotropic virus type 1 infection.

Rocha-Júnior MC, Haddad R, Cilião Alves DC, de Deus Wagatsuma VM, Mendes-Junior CT, Deghaide NH, Takayanagui OM, Covas DT, Donadi EA, Kashima S.

Tissue Antigens. 2012 Aug;80(2):143-50. doi: 10.1111/j.1399-0039.2012.01887.x. Epub 2012 May 15.

PMID:
22587568
38.

Using the National Institute of Health Stroke Scale to predict dysphagia in acute ischemic stroke.

Okubo PC, Fábio SR, Domenis DR, Takayanagui OM.

Cerebrovasc Dis. 2012;33(6):501-7. doi: 10.1159/000336240. Epub 2012 Apr 25.

39.

The contribution of a murine CNS-TB model for the understanding of the host-pathogen interactions in the formation of granulomas.

Zucchi FC, Pelegrini-da-Silva A, Neder L, Silva CL, Tsanaclis AM, Takayanagui OM.

J Neurosci Methods. 2012 Apr 30;206(1):88-93. doi: 10.1016/j.jneumeth.2012.02.015. Epub 2012 Feb 24.

PMID:
22387263
40.

Medical management of neurocysticercosis.

Takayanagui OM, Odashima NS, Bonato PS, Lima JE, Lanchote VL.

Expert Opin Pharmacother. 2011 Dec;12(18):2845-56. doi: 10.1517/14656566.2011.634801. Epub 2011 Nov 15. Review.

PMID:
22082143
41.

Seropositive antiaquaporin-4 antibody associated with multisegmental myelitis in a patient with paracoccidioidomycosis.

Brum DG, Donadi EA, dos Santos AC, Takayanagui OM, Marques W Jr, Barreira AA.

J Neurol Sci. 2011 Oct 15;309(1-2):151-3. doi: 10.1016/j.jns.2011.06.045. Epub 2011 Jul 30.

PMID:
21803375
42.

Minimal residual disease in cerebrospinal fluid at diagnosis: a more intensive treatment protocol was able to eliminate the adverse prognosis in children with acute lymphoblastic leukemia.

Biojone E, Queiróz Rde P, Valera ET, Odashima NS, Takayanagui OM, Viana MB, Tone LG, Scrideli CA.

Leuk Lymphoma. 2012 Jan;53(1):89-95. doi: 10.3109/10428194.2011.606939. Epub 2011 Aug 24.

PMID:
21774746
43.

The use of a neck brace does not influence visual vertical perception.

Funabashi M, Silva NN, Watanabe LM, Santos-Pontelli TE, Colafêmina JF, Carneiro AA, Takayanagui OM.

Arq Neuropsiquiatr. 2011 Jun;69(3):509-12.

44.

Albendazole-praziquantel interaction in healthy volunteers: kinetic disposition, metabolism and enantioselectivity.

Lima RM, Ferreira MA, de Jesus Ponte Carvalho TM, Dumêt Fernandes BJ, Takayanagui OM, Garcia HH, Coelho EB, Lanchote VL.

Br J Clin Pharmacol. 2011 Apr;71(4):528-35. doi: 10.1111/j.1365-2125.2010.03874.x.

45.

Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis.

Garcia HH, Lescano AG, Lanchote VL, Pretell EJ, Gonzales I, Bustos JA, Takayanagui OM, Bonato PS, Horton J, Saavedra H, Gonzalez AE, Gilman RH; Cysticercosis Working Group in Peru.

Br J Clin Pharmacol. 2011 Jul;72(1):77-84. doi: 10.1111/j.1365-2125.2011.03945.x.

46.

Unusual presentation of brain aspergillosis in chronic granulomatous disease.

Roxo P Jr, de Menezes UP, Condino-Neto A, Ferriani VP, Takayanagui OM.

Pediatr Neurol. 2010 Dec;43(6):442-4. doi: 10.1016/j.pediatrneurol.2010.06.020.

PMID:
21093739
47.

How frequent is the association of neurocysticercosis and mesial temporal lobe epilepsy with hippocampal sclerosis?

Bianchin MM, Velasco TR, Wichert-Ana L, Takayanagui OM, Leite JP, Sakamoto AC.

Epilepsia. 2010 Nov;51(11):2359-60. doi: 10.1111/j.1528-1167.2010.02735.x. No abstract available.

48.

HLA-G 14-bp insertion/deletion polymorphism is a risk factor for HTLV-1 infection.

Haddad R, Cilião Alves DC, Rocha-Junior MC, Azevedo R, Pombo-de-Oliveira MS, Takayanagui OM, Donadi EA, Covas DT, Kashima S.

AIDS Res Hum Retroviruses. 2011 Mar;27(3):283-8. doi: 10.1089/aid.2010.0165. Epub 2010 Oct 26.

PMID:
20977358
49.

The increasing female participation in authorship of articles published in neurology in Brazil.

Takayanagui OM, Livramento JA.

Arq Neuropsiquiatr. 2009 Sep;67(3B):914-6.

50.

Neurosyphilis in the age of AIDS: clinical and laboratory features.

Gitaí LL, Jaláli PS, Takayanagui OM.

Neurol Sci. 2009 Dec;30(6):465-70. doi: 10.1007/s10072-009-0134-7. Epub 2009 Sep 19.

PMID:
19768370

Supplemental Content

Loading ...
Support Center